Effect of Biodanza on Desire, Excitation and Sexual Inhibition

the objective of this study was to examine the effects of a 10 weeks biodanza program on the sexual desire and inhibition/arousal of a sample of healthy young adults.

A randomized clinical study was carried out, involving a total of 86 young adults divided into Intervention Group (BG) and Control Group (CG), carrying out biodanza sessions during 10 weeks. The Sexual Desire Inventory (SDI) and the Sexual Inhibition/Sexual Arousal-Short Form Scale (SIS/SES-SF) were completed before and after the intervention.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Sexual Desire Disorder Mental Disorders Sexual Arousal Disorder Sexual Dysfunctions, Psychological Sexual Inhibition

Age range

18 year–30 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Universidad de Almería

Almería, 04120, Spain

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

at least 18 years old
having correctly completed the online questionnaire.
to attend a minimum of eight Biodanza sessions.

Exclusion criteria

exceed 30 years old.
the presence of some type of physical or mental disability that could prevent their participation in the therapy or the completion of the questionnaires.

Treatment and study plan

Biodanza

Other

Intervention group received a total of 10 sessions, once a week, over the course of two months. Each session lasted 60 minutes. All sessions began with a 10-minute warm-up period combining music and low-intensity movements as a welcome round, followed individual exercises, in pairs and/or groups, which included dance combined with exercises based on the five lines of Biodanza (vitality, sexuality, creativity, affectivity and transcendence). Finally, a celebration and farewell round of 10 minutes was held. At the end of each session, the participants were asked to share their experiences with the rest of the group.

Other names: Dance

Primary outcomes

Sexual desire

Time frame: 3 months

Sexual Desire Inventory (SDI) formed by 13 items, divided into dyadic sexual desire (Dyadic SD) (items 1-9) and solitary sexual desire (Solitary SD) (items 10-13), and valued by a Likert scale according to frequency (0 = never, and 7 = more than once a day), and intensity (0 = not desire, and 8 = strong desire), in a total range between 0 and 101 points, being higher the desire the greater the response result.
Sexual excitement/sexual inhibition

Time frame: 3 months

Sexual Inhibition/Sexual Excitement Scales - Short Form consists of 14 items with responses assessed using a Likert scale 1-4 (1 = completely agree; 4 = completely disagree) that measure three sub-scales: Sexual Excitation Scale (SES) (items 1, 3, 8, 10, 11, 14) with a score range between 4 and 16; Sexual Inhibition Scale 1 (SIS1) (items 4, 9, 12, 13) related to distraction/concentration in sexual performance, with a range between 4 and 16, and Sexual Inhibition Scale 2 (SIS2) (items 2, 5, 6, 7) related to the fear to be discovered or to contract some type of sexually transmitted infection (STI), with a range between 4 and 16.

Sponsors and collaborators

Lead sponsor

Universidad de Almeria

Other

Registry information

Official study title

Effect of a Biodanza Program on Desire, Excitation and Sexual Inhibition in Young Adults. A Randomized Pilot Study

Important dates

Study start: 2018
Primary completion: 2018
Study completion: 2018
First posted: Oct 25, 2018
Registry last updated: Oct 29, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed